HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kristen Reipas Selected Research

BI D1870

8/2015Inhibition of RSK with the novel small-molecule inhibitor LJI308 overcomes chemoresistance by eliminating cancer stem cells.
7/2012Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kristen Reipas Research Topics

Disease

2Triple Negative Breast Neoplasms
07/2012 - 07/2010
2Breast Neoplasms (Breast Cancer)
07/2012 - 07/2010
2Tics (Tic)
07/2012 - 07/2010
1Neoplasms (Cancer)
08/2015

Drug/Important Bio-Agent (IBA)

2BI D1870IBA
08/2015 - 07/2012
2Transcription Factors (Transcription Factor)IBA
07/2012 - 07/2010
1LuteolinIBA
08/2015
1Messenger RNA (mRNA)IBA
07/2012
1Small Interfering RNA (siRNA)IBA
07/2012
190-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA
07/2012
1Progesterone Receptors (Progesterone Receptor)IBA
07/2010
1Phosphotransferases (Kinase)IBA
07/2010
1Aldehyde Dehydrogenase 1 FamilyIBA
07/2010
1tyrosine receptor (receptor, tyrosine)IBA
07/2010

Therapy/Procedure

1Drug Therapy (Chemotherapy)
07/2010
1Therapeutics
07/2010